Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 20, 2022
Product Development
Next-gen NK cell enhancements in the clinic
Companies are turning to tumor targeting, IL-15 expression and alternate cell sourcing to boost the potency and longevity of NK cell therapies
BioCentury | Aug 27, 2021
Distillery Therapeutics
Inhibiting multiple cell death pathways to extend neutrophil shelf life for transfusion
BioCentury | Jun 15, 2017
Tools & Techniques
Breaking the barrier
Companies are finally finding ways to develop cell-penetrating biologics
BioCentury | Dec 10, 2016
Product Development
Rules of the road
Why early management of CRS may cut CAR T toxicity without denting efficacy
BioCentury | Nov 2, 2015
Emerging Company Profile
Targeted disruption
PEP-Therapy's peptides block specific protein-protein interactions
BioCentury | Feb 2, 2015
Product Development
Remote controlled CARs
Intrexon, Ziopharm & MD Anderson assemble remote-controlled multi-gene CAR kit
BioCentury | Jan 22, 2015
Distillery Techniques
Techniques: Cartilagenous extracellular matrix (ECM) templates
Items per page:
1 - 10 of 14